Nueroprotection in Parkinson's disease by selegline (prospective, randomized, double-blind, placebo-controlled studies)

From Riederer and Lachenmayer 2003.
Exp Neurobiol 2011;20:1~17 https://doi.org/10.5607/en.2011.20.1.1
© Exp Neurobiol
© 2019. The Korean Society for Brain and Neural Sciences. / Powered by INFOrang Co., Ltd